With VAXXITEK® HVT+IBD+H5, Boehringer Ingelheim is expanding its proven VAXXITEK® range with a new vaccine that protects against three severe poultry diseases: Marek’s disease, Infectious Bursal ...

In a significant boost to the nation's poultry industry, Boehringer Ingelheim has announced the launch of its innovative ...

Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well ...

With VAXXITEK® HVT+IBD+H5, Boehringer Ingelheim is expanding its proven VAXXITEK® range with a new vaccine that protects ...

Results We included 41 RCTs and 15 companion reports comprising 8 vaccine types and 206 032 participants. Vaccines may prevent LCI compared with placebo, with high-dose trivalent inactivated influenza ...

Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...

VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek's disease, Infectious Bursal ...

The objective of this study is to develop a multivalent HCV vaccine to increase the antigenic coverage. Design We designed a trivalent vaccine containing sE2 from genotype 1a, 1b and 3a. Mice and ...

The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in securities of small- to mid-capitalization companies.

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...